Nkwadebe "Ranitidine": egosi maka ojiji, mejupụtara na Njirimara

Ọrịa nke eriri afọ tract - a nnọọ nkịtị nsogbu nke na-emetụta ndị mmadụ n'agbanyeghị afọ ole na okike. Ka ihe atụ, mgbu mgbe a chọpụtara na-eto eto na ụfọdụ na-eto eto ụmụ. Ọ dabara nke ọma, nkà mmụta ọgwụ ọgbara-enye ọtụtụ ngwá ọrụ maka ọgwụgwọ nke mkpali Filiks nke digestive tract. Na otu onye n'ime ha bụ nkwadebe "Ranitidine". Egosi maka ojiji na a usọbọ bụ sara mbara nke ukwuu. Ya mere, ihe ndị a gụnyere ná ya mejupụtara na otú irè dị otú ahụ a na ngwá ọrụ?

Nkwadebe "Ranitidine": Structure na mejupụtara

Isi nọ n'ọrụ compound bụ a hypochlorite ọgwụ ranitidine. Ke eke ụdị - a granular ọcha ntụ ntụ (mgbe ụfọdụ na a acha tinge) ndị e ji mara isi nke sọlfọ na-elu ilu uto. Nke a na umi nwere emegide Njirimara megide histamine H2 anabata.

The ọgwụ dị ma n'ụdị mbadamba ma ọ bụ na ihe ngwọta maka intramuscular ma ọ bụ igba ogwu n'akwara ochichi. E nwekwara a na-akpọ "effervescent" mbadamba maka akwadebe otu okenye ihe ngwọta.

Mbadamba dị gburugburu, bi-convex udi, n'elu kpuchie na ìhè oroma shei. Inyeaka bekee na-eji: sodium lauryl sulfate, microcrystalline cellulose, colloidal sịlịkọn dioxide, ọka starch, magnesium stearate, titanium dioxide, hypromellose, polyethylene glycol 6000, ethylcellulose odo e ji esiji ákwà.

Ka ụbọchị, pharmacological ụlọ ọrụ na-enye mbadamba, nke nwere ma 150 mg ma ọ bụ 300 mg nke nọ n'ọrụ umi. Injectable ngwọta dị na iko vials na 2 ml olu.

Pharmacological Njirimara "Ranitidine" ọgwụ

Dị ka ekwuola, isi n'ọrụ mgwa nke ọgwụ na-egbochi ndị H2 histamine retsentory. A ọgwụ eme ihe bụ isi na-arụ ọrụ nke parietal sel nke gastric mucosa. Mmụọ nhọrọ gbochie hydrochloric acid, nke na-eduga a ọnụ na olu enwupụta gastric ihe ọṅụṅụ, ma belata ya acidity. Site n'ụzọ, nke a bụ ya mere nkwadebe "Ranitidine" nrekasi obi bụ nnọọ irè.

Ọ ga-kwuru na histamine ihe nnabata blockers belata ịta nke digestive enzymes (pepsin), na gastric ihe ọṅụṅụ. Mgbochi nke secretion emepụta ezigbo ọnọdụ na-agwọ ọrịa nke ọnyá na mucosa nke ndammana accelerates agwọ ọrịa usoro.

Ọzọkwa, ifịk ifịk ọgwụ mmiri emetụta gastroduodenal ebe, na-amụba ọrụ nke obodo na-echebe usoro, na-amụba oke nke na-echebe mucous secretion. The ọgwụ na-accelerates imu.

N'otu oge ọgwụ adịghị nwere ụfọdụ dị ize ndụ na mmetụta na-ahụ. Karịsịa, ọ na-adịghị emetụta ịta nke calcium ion na ọbara, ọ na-adịghị ichegbu na endocrine usoro enweghị mmetụta na usoro nke spermatogenesis. The ọmụmụ gosiri na ọgwụ na-enweghị carcinogenic mmetụta na-adịghị eme ka mmụba. N'aka nke ọzọ, ndị nọ n'ọrụ umi penetrates na placental mgbochi a na n'ime mmiri ara.

Mgbe anata ọgwụ na-ngwa ngwa etinye obi gị dum site na mgbidi nke digestive tract. Ya kacha ịta n'ime ọbara hụrụ mgbe naanị 2-3 awa. N'ọnọdụ ka ukwuu, mmetụta dịruru banyere 12 awa. N'oge metabolism ikpe tọghatara na imeju. Kpamkpam anyụpụ site akụrụ n'ime ụbọchị mgbe ochichi.

Nkwadebe "Ranitidine": egosi maka ojiji

A ọgwụ na ọtụtụ-eji dị ka ihe antiulcer n'ụlọnga. Otú ọ dị, e nwere ọtụtụ nsogbu na nke dọkịta idepụta ọgwụ "Ranitidine". Egosi maka ojiji na-agụnye:

• oké nrekasi obi;
• afo na obere bowel ọrịa;
• taa n'ọtụtụ ebe na ọgwụ ọjọọ, "Ranitidine" mgbu;
• ngosi maka ojiji na-esophagitis, nke e mere site na-atụba n'ime nkọlọ nke gastric ọdịnaya, ma ọ bụ jikọtara iro nke eziokwu nke mucosal anụ ahụ;
• na nkà mmụta ọgwụ na-enyere ndị mmadụ na dyspepsia n'ebe ndị ahụ, ọ bụrụ na ọ na-esonyere oké ihe mgbu na epigastric region, paired na nri;
• Nwa etinyere na ọgwụgwọ nke ụfọdụ benign etuto ahụ;
• ka adjunctive ọgwụ eji ọchịchọ pneumonitis na ọrịa ogbu ogbu na nkwonkwo;
• ngwá ọrụ bụ akụkụ nke ọgwụ nke na-agba ọbara ke n'elu ngalaba nke digestive usoro;
• dị ka a mgbochi ọgwụ kenyere ka ọrịa ndị na-nwere ịwa ahụ na eriri afọ tract akụkụ.

Otu nwere naanị iji mara na nnukwu ọrịa - na-abụghị nanị ọrịa na-achọ ọgwụgwọ na "Ranitidine" ọgwụ ọjọọ. Egosi maka ojiji agụnye ma mgbochi nke exacerbations nke-adịghị ala ala mgbu na peptic ọnyá afọ.

Olee na-na nkà mmụta ọgwụ?

N'ezie, tupu na iji ọgwụ kwesịrị ịga hụ dọkịta. All doses kpebisiri ike n'otu n'otu, ebe ọ bụ na ha na-adabere afọ na ọnọdụ nke onye ọrịa, ụdị ọrịa, nzube nke n'ikuku (ọgwụgwọ ma ọ bụ mgbochi):

• Okenye ọrịa na-egosi na mkpụrụ ọgwụ na a dose nke nọ n'ọrụ umi 150 mg ugboro abụọ n'ụbọchị. Mgbe ụfọdụ, ndị dọkịta nwere ike ikwu na-ewere mbadamba nkume abụọ tupu alakpu ụra.
• N'ihi na-egbochi ọbara ọgbụgba onye ọrịa na-agbara intramuscularly (ma ọ bụ intravenously) nke 0,05 - 0,1 g na etiti oge nke 6-8 awa (na dose nwere ike mụbara 0,9 g, ma ọ dị mkpa).
• -Eto eto, na-na-na 150 mg ugboro abụọ n'ụbọchị.
• Na ọgwụgwọ nke benign etuto ahụ na-atụ aro dose bụ 150 mg nke nọ n'ọrụ mgwa ugboro atọ n'ụbọchị.

Dị ka a na-achị, na ọgwụgwọ oge bụ n'etiti anọ ruo asatọ izu. Mgbe ọ na-abịa mgbochi, ọ na-atụ aro n'ihi na ụfọdụ ọrịa na-ewere ọgwụ ruo ọtụtụ ọnwa na mgbe ụfọdụ a afọ, ma mgbe nile ọgwụ na-elekọta ya anya mgbe niile endoscopic ọmụmụ.

Contraindications na ojiji nke ọgwụ ọjọọ, "Ranitidine"

Ka ọ bụla ọzọ ọgwụ, a ọgwụ ike ga-eji ọ bụghị ọ bụla ndidi. Karịsịa, a machibidoro iwu na-eji maka ọgwụgwọ nke ndị inyom n'oge ime na lactation, dị ka arụ ọrụ bekee nwere ike mfe banye n'ime n'ime mmiri ara ehi ma na-agafe na placental mgbochi. Contraindication bụ hypersensitivity ọ bụla akụrụngwa nke ọgwụ umi. "Ranitidine" na-adịghị eji na ọgwụgwọ nke ụmụ n'okpuru afọ 14.

Ọzọkwa, ngwá ọrụ eji na-ekwesịghị maka ọgwụgwọ nke ọrịa chọpụtara na imeju ma ọ bụ akụrụ odida, na nnukwu porphyria na imeju.

Gịnị mmetụta nwere ike ime n'oge ọgwụgwọ?

N'ụzọ dị mwute, ifịk ọgwụ akụrụngwa emetụta ihe fọrọ nke nta niile ngwa usoro. Ya mere, na ụfọdụ ndị ọrịa ọgwụ nwere ike paired na ụfọdụ oghom Jeremaya mere:

• Ọtụtụ mgbe e nwere isi ọwụwa, iro ụra, inwekwu nchegbu, ike ọgwụgwụ, ajụ obubu, bịara ikiri ọhụụ. Na ọzọ dị oké njọ mgbe, ọgwụ nwere ike ime ka ọgba aghara, na mmepe nke ịda mbà n'obi, ịmụ anya arọ nrọ.
• Ekwe Omume imebi nke obi usoro, akpan akpan, a ọnụ ke ọbara mgbali, aplastic ma ọ bụ hemolytic anaemia, arrhythmia, tachycardia, thrombocytopenia, adịkarịghị - ụmị ọkpụkpụ hypoplasia.
• Nfụkasị Jeremaya na-esokarị site na ọdịdị nke anụ ọkụ ọkụ na itching, fever, ọzịza, erythema. Nnọọ adịkarịghị ọgwụ na-eduga ná anaphylactic ujo.
• Nwere ike ime ka ọgbụgbọ na vomiting, abdominal mgbu. Nnọọ na-adịghị ọgwụgwọ-eduga ná mmepe nke pancreatitis na ụdị ụfọdụ nke ịba ọcha n'anya.

Na omume nke ọ bụla mmetụta kwesịrị ịkwụsị ewere ọgwụ na-akọwa na ihe mgbaàmà na nlekọta ahụ ike na pụta.

Ozi ndị ọzọ banyere nkà mmụta ọgwụ

Tupu ewere a ọgwụ, dị ka a na-achị, rụrụ a ọma nnyocha, ebe ọ bụ na ọ dị oké mkpa iji hụ na-anọghị nke etuto ahụ na afo na obere eriri afọ. The eziokwu na ọgwụ pụrụ ikpuchi isi mgbaàmà nke cancer.

Ogologo oge ọgwụgwọ nke ọrịa na a ebelatawo dịghịzi usoro na ike ịgwụ nke ahụ nwere ike ime ka nje ujo afo arọ.

N'ikuku "Ranitidine" ga-akwụsị nwayọọ nwayọọ, ụbọchị, na-ebelata dose. Mberede ndọrọ ego nke ọgwụ ọjọọ pụrụ ịkpata ihe exacerbation nke peptic ọnyá afọ ọrịa.

Dị ka ọgwụ interactions "Ranitidine" na ndị ọzọ ọgwụ ọjọọ eme ihe?

Ọtụtụ mgbe ọgwụ na-agụnye ma ndị nke a agwọ ọrịa na preparations, antacids, nke belata acidity ke afo. N'ọnọdụ dị otú ahụ, na-ezumike n'etiti oriri nke ọgwụ ndị a ga-dịkarịa ala 1-2 awa.

Nkwadebe "Ranitidine" egbochikwa absorption ketoconazole, na-egbochi metabolic Filiks ke imeju diazepam, metronidazole, lignocaine na ụfọdụ ndị ọzọ preparations. Na mberede, ise siga nke ukwuu ebelata mmetụta si n'ikuku nke ngwá ọrụ.

Nkwadebe "Ranitidine": ndidi reviews

Nyocha nke ọrịa ndị na-eji ọgwụ ọjọọ, ukwuu n'ime mma. People usọrọ n'ezie anya mmetụta nke a ọgwụgwọ. Nkwadebe "Ranitidine" na-enyere kpochapụ nrekasi obi, eliminates isi mgbaàmà nke mgbu. The uru nke a ọgwụ nwere ike ekewet, na a dịtụ ọnụ price. Oghom Jeremaya mere bụ oké ụkọ.